Papillary thyroid carcinoma with tall cell features is as aggressive as tall cell variant: a meta-analysis

There are still ongoing debates as to which cut-off percentage of tall cell (TC) should be used to define tall cell variant (TCV) papillary thyroid carcinoma (PTC). In this meta-analysis, we aimed to investigate the clinicopathological significance of PTC with tall cell features (PTC-TCF, PTC with 1...

Full description

Bibliographic Details
Main Authors: Huy Gia Vuong, Nguyen Phuoc Long, Nguyen Hoang Anh, Tran Diem Nghi, Mai Van Hieu, Le Phi Hung, Tadao Nakazawa, Ryohei Katoh, Tetsuo Kondo
Format: Article
Language:English
Published: Bioscientifica 2018-11-01
Series:Endocrine Connections
Subjects:
Online Access:https://ec.bioscientifica.com/view/journals/ec/7/12/EC-18-0333.xml
id doaj-76e3f9bb50f6420292192f2f273b4ec9
record_format Article
spelling doaj-76e3f9bb50f6420292192f2f273b4ec92020-11-25T00:39:14ZengBioscientificaEndocrine Connections2049-36142049-36142018-11-01712R286R293https://doi.org/10.1530/EC-18-0333Papillary thyroid carcinoma with tall cell features is as aggressive as tall cell variant: a meta-analysisHuy Gia Vuong0Nguyen Phuoc Long1Nguyen Hoang Anh2Tran Diem Nghi3Mai Van Hieu4Le Phi Hung5Tadao Nakazawa6Ryohei Katoh7Tetsuo Kondo8Department of Pathology, University of Yamanashi, Yamanashi, JapanFaculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet NamSchool of Medicine, Viet Nam National University, Ho Chi Minh City, Viet NamSchool of Medicine, Viet Nam National University, Ho Chi Minh City, Viet NamSchool of Medicine, Viet Nam National University, Ho Chi Minh City, Viet NamFaculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet NamDepartment of Pathology, University of Yamanashi, Yamanashi, JapanDepartment of Pathology, University of Yamanashi, Yamanashi, JapanDepartment of Pathology, University of Yamanashi, Yamanashi, JapanThere are still ongoing debates as to which cut-off percentage of tall cell (TC) should be used to define tall cell variant (TCV) papillary thyroid carcinoma (PTC). In this meta-analysis, we aimed to investigate the clinicopathological significance of PTC with tall cell features (PTC-TCF, PTC with 10–50% of TCs) in comparison with classical PTC and TCVPTC (PTC with more than 50% of TCs) to clarify the controversial issue. Four electronic databases including PubMed, Web of Science, Scopus and Virtual Health Library were accessed to search for relevant articles. We extracted data from published studies and pooled into odds ratio (OR) and its corresponding 95% confidence intervals (CIs) using random-effect modeling. Nine studies comprising 403 TCVPTCs, 325 PTC-TCFs and 3552 classical PTCs were included for meta-analyses. Overall, the clinicopathological profiles of PTC-TCF including multifocality, extrathyroidal extension, lymph node metastasis, distant metastasis and patient mortality were not statistically different from those of TCVPTC. Additionally, PTC-TCF and TCVPTC were both associated with an increased risk for aggressive clinical courses as compared to classical PTC. The prevalence of BRAF mutation in PTC-TCF and TCVPTC was comparable and both were significantly higher than that in classical PTC. The present meta-analysis demonstrated that even a PTC comprising only 10% of TCs might be associated with a poor clinical outcome. Therefore, the proportions of PTC in PTC should be carefully estimated and reported even when the TC component is as little as 10%.https://ec.bioscientifica.com/view/journals/ec/7/12/EC-18-0333.xmlpapillary thyroid carcinomatall cell featuretall cellmeta-analysisreviewBRAFTERTprognosissurvivalaggressive
collection DOAJ
language English
format Article
sources DOAJ
author Huy Gia Vuong
Nguyen Phuoc Long
Nguyen Hoang Anh
Tran Diem Nghi
Mai Van Hieu
Le Phi Hung
Tadao Nakazawa
Ryohei Katoh
Tetsuo Kondo
spellingShingle Huy Gia Vuong
Nguyen Phuoc Long
Nguyen Hoang Anh
Tran Diem Nghi
Mai Van Hieu
Le Phi Hung
Tadao Nakazawa
Ryohei Katoh
Tetsuo Kondo
Papillary thyroid carcinoma with tall cell features is as aggressive as tall cell variant: a meta-analysis
Endocrine Connections
papillary thyroid carcinoma
tall cell feature
tall cell
meta-analysis
review
BRAF
TERT
prognosis
survival
aggressive
author_facet Huy Gia Vuong
Nguyen Phuoc Long
Nguyen Hoang Anh
Tran Diem Nghi
Mai Van Hieu
Le Phi Hung
Tadao Nakazawa
Ryohei Katoh
Tetsuo Kondo
author_sort Huy Gia Vuong
title Papillary thyroid carcinoma with tall cell features is as aggressive as tall cell variant: a meta-analysis
title_short Papillary thyroid carcinoma with tall cell features is as aggressive as tall cell variant: a meta-analysis
title_full Papillary thyroid carcinoma with tall cell features is as aggressive as tall cell variant: a meta-analysis
title_fullStr Papillary thyroid carcinoma with tall cell features is as aggressive as tall cell variant: a meta-analysis
title_full_unstemmed Papillary thyroid carcinoma with tall cell features is as aggressive as tall cell variant: a meta-analysis
title_sort papillary thyroid carcinoma with tall cell features is as aggressive as tall cell variant: a meta-analysis
publisher Bioscientifica
series Endocrine Connections
issn 2049-3614
2049-3614
publishDate 2018-11-01
description There are still ongoing debates as to which cut-off percentage of tall cell (TC) should be used to define tall cell variant (TCV) papillary thyroid carcinoma (PTC). In this meta-analysis, we aimed to investigate the clinicopathological significance of PTC with tall cell features (PTC-TCF, PTC with 10–50% of TCs) in comparison with classical PTC and TCVPTC (PTC with more than 50% of TCs) to clarify the controversial issue. Four electronic databases including PubMed, Web of Science, Scopus and Virtual Health Library were accessed to search for relevant articles. We extracted data from published studies and pooled into odds ratio (OR) and its corresponding 95% confidence intervals (CIs) using random-effect modeling. Nine studies comprising 403 TCVPTCs, 325 PTC-TCFs and 3552 classical PTCs were included for meta-analyses. Overall, the clinicopathological profiles of PTC-TCF including multifocality, extrathyroidal extension, lymph node metastasis, distant metastasis and patient mortality were not statistically different from those of TCVPTC. Additionally, PTC-TCF and TCVPTC were both associated with an increased risk for aggressive clinical courses as compared to classical PTC. The prevalence of BRAF mutation in PTC-TCF and TCVPTC was comparable and both were significantly higher than that in classical PTC. The present meta-analysis demonstrated that even a PTC comprising only 10% of TCs might be associated with a poor clinical outcome. Therefore, the proportions of PTC in PTC should be carefully estimated and reported even when the TC component is as little as 10%.
topic papillary thyroid carcinoma
tall cell feature
tall cell
meta-analysis
review
BRAF
TERT
prognosis
survival
aggressive
url https://ec.bioscientifica.com/view/journals/ec/7/12/EC-18-0333.xml
work_keys_str_mv AT huygiavuong papillarythyroidcarcinomawithtallcellfeaturesisasaggressiveastallcellvariantametaanalysis
AT nguyenphuoclong papillarythyroidcarcinomawithtallcellfeaturesisasaggressiveastallcellvariantametaanalysis
AT nguyenhoanganh papillarythyroidcarcinomawithtallcellfeaturesisasaggressiveastallcellvariantametaanalysis
AT trandiemnghi papillarythyroidcarcinomawithtallcellfeaturesisasaggressiveastallcellvariantametaanalysis
AT maivanhieu papillarythyroidcarcinomawithtallcellfeaturesisasaggressiveastallcellvariantametaanalysis
AT lephihung papillarythyroidcarcinomawithtallcellfeaturesisasaggressiveastallcellvariantametaanalysis
AT tadaonakazawa papillarythyroidcarcinomawithtallcellfeaturesisasaggressiveastallcellvariantametaanalysis
AT ryoheikatoh papillarythyroidcarcinomawithtallcellfeaturesisasaggressiveastallcellvariantametaanalysis
AT tetsuokondo papillarythyroidcarcinomawithtallcellfeaturesisasaggressiveastallcellvariantametaanalysis
_version_ 1725294457213943808